Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study
Real-world clinical practice corroborates the findings from clinical trials, confirming the effectiveness and safety of ENZA in mHSPC patients.
Authors
- Mike Wenzel (ORCID: https://orcid.org/0000-0002-4338-0889)
- Maria Teresa Bourlon (ORCID: https://orcid.org/0000-0002-3116-912X)
- Ondřej Fiala (ORCID: https://orcid.org/0000-0002-4096-7385)
- Edoardo Lenci (ORCID: https://orcid.org/0000-0002-4011-7292)
- Bohuslav Melichar (ORCID: https://orcid.org/0000-0002-5474-6866)
- Zin Myint (ORCID: https://orcid.org/0000-0002-3479-4203)
- Pasquale Rescigno (ORCID: https://orcid.org/0000-0002-4668-4765)
- María Natalia Gandur Quiroga (ORCID: https://orcid.org/0000-0001-7034-0842)
- Thomas Büttner (ORCID: https://orcid.org/0000-0003-0316-9621)
- Alonso-Gordoa Teresa
- Emmanuel Seront (ORCID: https://orcid.org/0000-0003-4807-7472)
- Jindřich Kopecký (ORCID: https://orcid.org/0000-0002-4126-0410)
- Molina-Cerrillo Javier
- Laura Bernal Vaca (ORCID: https://orcid.org/0000-0002-8394-2698)
- Alessandra Mosca (ORCID: https://orcid.org/0000-0003-2538-8411)
- Francesco Massari (ORCID: https://orcid.org/0000-0001-6476-6871)
- Sarah Scagliarini (ORCID: https://orcid.org/0000-0001-5814-2296)
- Martin Bögemann (ORCID: https://orcid.org/0000-0002-2569-4446)
- H. Harold Li
- Tomáš Büchler (ORCID: https://orcid.org/0000-0001-6667-994X)
- A. Poprach
- Álvaro Juárez
- Mimma Rizzo
- Matteo Santoni
- Jakub Kucharz
- Diana Matthews
- Emmanuel S. Antonarakis
- Yüksel Ürün
- Alejo Rodriguez-Vida
- Alessandro Rizzo
- Philipp Mandell
Institutions
- Goethe University Frankfurt (DE)
- University of Minnesota (US)
- Cliniques Universitaires Saint-Luc (BE)
- University of Kentucky (US)
- Ankara University (TR)
- Universität Hamburg (DE)
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital Bonn (DE)
- Markey Cancer Center (US)
- Ospedale Antonio Cardarelli (IT)
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
- The University of Kansas Cancer Center (US)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- University Hospital in Motol (CZ)
- University Hospital Münster (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Martini-Klinik (DE)
- Masaryk Memorial Cancer Institute (CZ)
- Ospedali Riuniti Marche Nord (IT)
- Azienda USL di Bologna (IT)
- Clínica Santa María (CO)
- Hospital Del Mar (ES)
- Istituto Tumori Bari (IT)
- University Hospital Frankfurt (DE)
- University Hospital Hradec Králové (CZ)
- Velindre Cancer Centre (GB)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Candiolo Cancer Institute (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Hospital Jerez Puerta del Sur (ES)
- Instituto de Oncología de Rosario (AR)
- Hospital Universitario Ramón y Cajal (ES)
- Fundación Universitaria Sanitas (CO)
- Ospedale di Macerata
- University of Macerata (IT)
- Palacký University Olomouc (CZ)
- Newcastle University (GB)
- University of Bologna (IT)
Publication Details
- Journal
- Prostate Cancer and Prostatic Diseases
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1038/s41391-025-01067-3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- National Cancer Institute